S&P 500   4,349.64 (+-0.01%)
DOW   34,271.11 (+0.30%)
QQQ   344.59 (+0.01%)
AAPL   160.78 (+0.68%)
MSFT   301.49 (+1.61%)
FB   297.89 (+1.11%)
GOOGL   2,606.62 (+0.85%)
AMZN   2,820.00 (+1.53%)
TSLA   859.23 (-8.34%)
NVDA   220.94 (-2.98%)
BABA   112.32 (-0.93%)
NIO   21.48 (-5.21%)
AMD   104.12 (-5.95%)
CGC   6.95 (-3.87%)
MU   79.88 (-2.55%)
GE   88.67 (-0.73%)
T   24.03 (-0.91%)
F   19.75 (-0.80%)
DIS   135.54 (+1.45%)
AMC   14.87 (-6.71%)
PFE   53.87 (+1.62%)
ACB   3.86 (-4.93%)
BA   191.39 (-1.48%)
S&P 500   4,349.64 (+-0.01%)
DOW   34,271.11 (+0.30%)
QQQ   344.59 (+0.01%)
AAPL   160.78 (+0.68%)
MSFT   301.49 (+1.61%)
FB   297.89 (+1.11%)
GOOGL   2,606.62 (+0.85%)
AMZN   2,820.00 (+1.53%)
TSLA   859.23 (-8.34%)
NVDA   220.94 (-2.98%)
BABA   112.32 (-0.93%)
NIO   21.48 (-5.21%)
AMD   104.12 (-5.95%)
CGC   6.95 (-3.87%)
MU   79.88 (-2.55%)
GE   88.67 (-0.73%)
T   24.03 (-0.91%)
F   19.75 (-0.80%)
DIS   135.54 (+1.45%)
AMC   14.87 (-6.71%)
PFE   53.87 (+1.62%)
ACB   3.86 (-4.93%)
BA   191.39 (-1.48%)
S&P 500   4,349.64 (+-0.01%)
DOW   34,271.11 (+0.30%)
QQQ   344.59 (+0.01%)
AAPL   160.78 (+0.68%)
MSFT   301.49 (+1.61%)
FB   297.89 (+1.11%)
GOOGL   2,606.62 (+0.85%)
AMZN   2,820.00 (+1.53%)
TSLA   859.23 (-8.34%)
NVDA   220.94 (-2.98%)
BABA   112.32 (-0.93%)
NIO   21.48 (-5.21%)
AMD   104.12 (-5.95%)
CGC   6.95 (-3.87%)
MU   79.88 (-2.55%)
GE   88.67 (-0.73%)
T   24.03 (-0.91%)
F   19.75 (-0.80%)
DIS   135.54 (+1.45%)
AMC   14.87 (-6.71%)
PFE   53.87 (+1.62%)
ACB   3.86 (-4.93%)
BA   191.39 (-1.48%)
S&P 500   4,349.64 (+-0.01%)
DOW   34,271.11 (+0.30%)
QQQ   344.59 (+0.01%)
AAPL   160.78 (+0.68%)
MSFT   301.49 (+1.61%)
FB   297.89 (+1.11%)
GOOGL   2,606.62 (+0.85%)
AMZN   2,820.00 (+1.53%)
TSLA   859.23 (-8.34%)
NVDA   220.94 (-2.98%)
BABA   112.32 (-0.93%)
NIO   21.48 (-5.21%)
AMD   104.12 (-5.95%)
CGC   6.95 (-3.87%)
MU   79.88 (-2.55%)
GE   88.67 (-0.73%)
T   24.03 (-0.91%)
F   19.75 (-0.80%)
DIS   135.54 (+1.45%)
AMC   14.87 (-6.71%)
PFE   53.87 (+1.62%)
ACB   3.86 (-4.93%)
BA   191.39 (-1.48%)
NASDAQ:BNFT

Benefitfocus Stock Forecast, Price & News

$10.94
-0.05 (-0.45%)
(As of 01/27/2022 12:38 PM ET)
Add
Compare
Today's Range
$10.84
$11.06
50-Day Range
$9.97
$11.29
52-Week Range
$9.87
$17.58
Volume
1,665 shs
Average Volume
181,564 shs
Market Capitalization
$365.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.66
30 days | 90 days | 365 days | Advanced Chart
Receive BNFT News and Ratings via Email

Sign-up to receive the latest news and ratings for Benefitfocus and its competitors with MarketBeat's FREE daily newsletter.


Benefitfocus logo

About Benefitfocus

Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans. The Benefitfocus Platform has a multi-tenant architecture and has a user-friendly interface designed for employees to access their benefits in one place. The company's solutions support medical benefit plans and non-medical benefits, such as, dental, life, disability insurance, income protection, digital health, and financial wellness. Its target market comprises of the Employers and Health Plans market segments. The Employers market segment includes the sale of technology solutions on an annually recurring or multi-year subscription basis. Employers use these solutions to streamline benefits processes and control costs, keep up with regulatory requirements, and offer a variety of benefit options to attract, retain, and motivate employees. The Health Plans market segment is involved in the sale of solutions on a subscription basis to health plans, enabling the expansion of the company's overall footprint in the benefits marketplace by aggregating key constituents, including consumers, employers, and brokers. Health Plans, also known as health insurers, health insuran

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BNFT
Employees
1,200
Year Founded
N/A

Sales & Book Value

Annual Sales
$268.14 million
Cash Flow
$0.12 per share
Book Value
($1.51) per share

Profitability

Net Income
$-24.30 million
Pretax Margin
-12.09%

Debt

Price-To-Earnings

Miscellaneous

Free Float
26,176,000
Market Cap
$365.72 million
Optionable
Optionable

Company Calendar

Last Earnings
11/02/2021
Today
1/27/2022
Next Earnings (Estimated)
3/14/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.41 out of 5 stars

Computer And Technology Sector

235th out of 898 stocks

Prepackaged Software Industry

61st out of 284 stocks

Analyst Opinion: 3.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 0.6 5 -4 -3 -2 -1 -












Benefitfocus (NASDAQ:BNFT) Frequently Asked Questions

Is Benefitfocus a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Benefitfocus in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Benefitfocus stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BNFT, but not buy additional shares or sell existing shares.
View analyst ratings for Benefitfocus
or view top-rated stocks.

How has Benefitfocus' stock been impacted by COVID-19?

Benefitfocus' stock was trading at $10.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BNFT stock has increased by 7.1% and is now trading at $10.94.
View which stocks have been most impacted by COVID-19
.

When is Benefitfocus' next earnings date?

Benefitfocus is scheduled to release its next quarterly earnings announcement on Monday, March 14th 2022.
View our earnings forecast for Benefitfocus
.

How were Benefitfocus' earnings last quarter?

Benefitfocus, Inc. (NASDAQ:BNFT) issued its quarterly earnings results on Tuesday, November, 2nd. The software maker reported ($0.19) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.23) by $0.04. The software maker earned $62.03 million during the quarter, compared to the consensus estimate of $59 million. During the same period in the previous year, the business posted ($0.20) EPS.
View Benefitfocus' earnings history
.

What guidance has Benefitfocus issued on next quarter's earnings?

Benefitfocus issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $254 million-$260 million, compared to the consensus revenue estimate of $257.44 million.

What price target have analysts set for BNFT?

2 brokerages have issued 12 month target prices for Benefitfocus' stock. Their forecasts range from $13.00 to $17.00. On average, they expect Benefitfocus' stock price to reach $15.00 in the next year. This suggests a possible upside of 37.1% from the stock's current price.
View analysts' price targets for Benefitfocus
or view top-rated stocks among Wall Street analysts.

Who are Benefitfocus' key executives?

Benefitfocus' management team includes the following people:
  • Matt Levin, President, Chief Executive Officer & Director
  • Ken Haderer, Executive Vice President-Global Operations
  • Alpana Wegner, Chief Financial Officer (LinkedIn Profile)
  • Sean Wechter, Chief Information Officer
  • Daniel Dennis, Chief Information Security Officer & VP

What is Steve Swad's approval rating as Benefitfocus' CEO?

9 employees have rated Benefitfocus CEO Steve Swad on Glassdoor.com. Steve Swad has an approval rating of 60% among Benefitfocus' employees. This puts Steve Swad in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Benefitfocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Benefitfocus investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Designer Brands (DBI), STMicroelectronics (STM), Athabasca Oil (ATH) and (HON).

What is Benefitfocus' stock symbol?

Benefitfocus trades on the NASDAQ under the ticker symbol "BNFT."

Who are Benefitfocus' major shareholders?

Benefitfocus' stock is owned by a variety of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (3.03%), CAPROCK Group Inc. (0.09%) and Cutler Group LP (0.00%). Company insiders that own Benefitfocus stock include Alpana Wegner, Annmarie Fini and James P Restivo.
View institutional ownership trends for Benefitfocus
.

Which institutional investors are selling Benefitfocus stock?

BNFT stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for Benefitfocus
or view top insider-selling stocks.

Which institutional investors are buying Benefitfocus stock?

BNFT stock was acquired by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., and CAPROCK Group Inc..
View insider buying and selling activity for Benefitfocus
or or view top insider-buying stocks.

How do I buy shares of Benefitfocus?

Shares of BNFT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Benefitfocus' stock price today?

One share of BNFT stock can currently be purchased for approximately $10.94.

How much money does Benefitfocus make?

Benefitfocus has a market capitalization of $365.72 million and generates $268.14 million in revenue each year. The software maker earns $-24.30 million in net income (profit) each year or ($1.16) on an earnings per share basis.

How many employees does Benefitfocus have?

Benefitfocus employs 1,200 workers across the globe.

What is Benefitfocus' official website?

The official website for Benefitfocus is www.benefitfocus.com.

Where are Benefitfocus' headquarters?

Benefitfocus is headquartered at 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492.

How can I contact Benefitfocus?

Benefitfocus' mailing address is 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492. The software maker can be reached via phone at (843) 849-7476, via email at [email protected], or via fax at 843-849-9485.


This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.